David Stephen Ojala

Title: David Stephen Ojala: Innovator in Gene Delivery Technologies

Introduction

David Stephen Ojala is a prominent inventor based in Berkeley, CA. He has made significant contributions to the field of gene delivery technologies, particularly through his work with adeno-associated viruses. With a total of 2 patents, Ojala's innovations are paving the way for advancements in gene therapy.

Latest Patents

Ojala's latest patents include "Adeno-associated virus capsid variants and methods of use thereof" and "Adeno-associated virus variants and methods of use thereof." The first patent provides recombinant adeno-associated virus virions with variant capsid proteins that enhance their ability to cross neuronal cell barriers and increase infectivity in neural stem and neuronal cells. This patent also outlines methods for delivering gene products to these cells and modifying target nucleic acids. The second patent focuses on recombinant adeno-associated virus virions that exhibit greater infectivity of target cells, along with methods for delivering gene products to individuals using these virions.

Career Highlights

David Stephen Ojala is affiliated with the University of California, where he continues to advance research in gene delivery systems. His work is instrumental in developing innovative solutions for gene therapy applications.

Collaborations

Ojala collaborates with notable colleagues, including David V Schaffer and Philip A Romero, who contribute to the research and development of gene delivery technologies.

Conclusion

David Stephen Ojala's contributions to the field of gene delivery through his innovative patents are significant. His work at the University of California and collaborations with esteemed colleagues further enhance the potential of gene therapy.